Virus's multipronged attack on bacteria points to new ways to fight infection

May 19, 2017 by Ryan O'hare
Phages attack a bacterium. Credit: Imperial College London

Researchers have uncovered how a virus uses a two-pronged attack against a single protein to kill bacteria.

The international group, led by scientists from the MRC Centre for Molecular Bacteriology & Infection at Imperial College London, believe their work could ultimately lead to new ways to combat bacterial infections.

The team made the discovery while studying a type of known as a T7 bacteriophage, which infects E. coli, the bacterium which can cause food poisoning.

The virus, which is hundreds of times smaller than a bacterium, selectively targets E.coli, hijacking the bacterium's biological functions to churn out more copies of itself.

Previously, a group led by Professor Ramesh Wigneshweraraj from the Department of Medicine and Professor Steve Matthews from the Department of Life Sciences, discovered that this virus attacks its bacterial host by interfering with E.coli's ability to switch on its genes.

They showed that the virus produces a protein called Gp2 which targets a crucial enzyme in the bacterium known as RNA polymerase (RNAP).

This enzyme is used by bacteria to transcribe their genetic code to strands of RNA, needed for making proteins.

RNAP is already a target for some antibiotics like rifamycins, used to treat tuberculosis and leprosy, which kill bacteria by binding to the enzyme and disrupting its ability to make RNA.

Virus's multipronged attack on bacteria points to new ways to fight infection
The structure of the Gp5.7 protein. Credit: Imperial College London

In the latest study, published in the journal Nucleic Acid Research, the international group, which involved researchers from the US, Russia and Israel, has shown that the virus also uses a second protein to target RNAP – forming a two-pronged attack against the same target in E.coli.

Doubling up

"These viruses are quite efficient killers. They don't have resources to spare, so typically they will develop one protein to kill one process," explained Professor Wigneshweraraj. "The novelty of our new research is that we have discovered that one virus has evolved two entirely different ways to attack the same bacterial target."

The group thinks that the first protein (Gp2) can only inhibit free forms of the enzyme – not actively transcribing DNA – in the bacterial cell during the early stages of infection.

However, later on in the attack, more RNAP becomes available. The virus produces the second (Gp5.7) to target the remaining enzymes and finish the job, resulting in a finely tuned process to kill the bacterium.

Professor Wigneshweraraj says that while the study is fundamental research and is a long way from being used in the clinic, the pharmaceutical industry could use the research to revisit existing targets in the bacterial cell for intervention.

"Our view is that by studying these proteins we can get truly new inspiration to hit on new ways to fight bacterial infections. If we can mimic the processes that viruses use, we may be able to create new forms of treatment – against proven antibiotic targets in bacteria," said Professor Wigneshweraraj.

The researchers say the next step is to focus more on how Gp5.7 binds to RNAP and to work out the exact mechanism by which the viruses take down the bacteria.

Explore further: Researchers take early step towards devising new antibiotics

More information: Aline Tabib-Salazar et al. Full shut-off of Escherichia coli RNA-polymerase by T7 phage requires a small phage-encoded DNA-binding protein, Nucleic Acids Research (2017). DOI: 10.1093/nar/gkx370

Related Stories

Researchers determine structure of tuberculosis drug target

April 6, 2017

Rutgers University scientists have determined the three-dimensional structure of the target of the first-line anti-tuberculosis drug rifampin. They have also discovered a new class of potential anti-tuberculosis drugs that ...

Biologists discover how viruses hijack cell's machinery

January 12, 2017

Biologists at UC San Diego have documented for the first time how very large viruses reprogram the cellular machinery of bacteria during infection to more closely resemble an animal or human cell—a process that allows these ...

Oxygen can wake up dormant bacteria for antibiotic attacks

December 8, 2016

Bacterial resistance does not come just through adaptation to antibiotics, sometimes the bacteria simply go to sleep. An international team of researchers is looking at compounds that attack bacteria's ability to go dormant ...

Recommended for you

Making biological drugs with spider silk protein

May 23, 2017

Researchers at Karolinska Institutet in Sweden have managed to synthesise lung surfactant, a drug used in the care of preterm babies, by mimicking the production of spider silk. Animal studies reveal it to be just as effective ...

A new tool for discovering nanoporous materials

May 23, 2017

Materials classified as "nanoporous" have structures (or "frameworks") with pores up to 100 nm in diameter. These include diverse materials used in different fields from gas separation, catalysis, and even medicine (e.g. ...

Taking a closer look at genetic switches in cancer

May 22, 2017

Many things go wrong in cells during the development of cancer. At the heart of the chaos are often genetic switches that control the production of new cells. In a particularly aggressive form of leukemia, called acute myeloid ...

Micro delivery service for fertilizers

May 22, 2017

Plants can absorb nutrients through their leaves as well as their roots. However, foliar fertilization over an extended period is difficult. In the journal Angewandte Chemie, German researchers have now introduced an efficient ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.